Copyright
©The Author(s) 2021.
World J Stem Cells. May 26, 2021; 13(5): 470-484
Published online May 26, 2021. doi: 10.4252/wjsc.v13.i5.470
Published online May 26, 2021. doi: 10.4252/wjsc.v13.i5.470
n | Mean | SD | Mean rank | χ2 | df | P value | |
Pre-test | 6 | 5.50 | 0.55 | 1.67 | 28.255 | 5 | 0.000 |
Post-test 1 wk | 6 | 5.67 | 0.82 | 1.83 | |||
Post-test 1 mo | 6 | 7.17 | 1.60 | 2.75 | |||
Post-test 2 mo | 6 | 8.33 | 2.25 | 3.83 | |||
Post-test 4 mo | 6 | 10.17 | 3.06 | 4.92 | |||
Post-test 12 mo | 6 | 13.00 | 2.83 | 6.00 |
- Citation: Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Boyalı O, Diren F, Can H, Genç A, Akkoç T, Karaöz E. Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study. World J Stem Cells 2021; 13(5): 470-484
- URL: https://www.wjgnet.com/1948-0210/full/v13/i5/470.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i5.470